0
Editorial |

Thank You, JAMA Peer Reviewers and Authors

Catherine D. DeAngelis, MD, MPH; Phil B. Fontanarosa, MD, MBA
[+] Author Affiliations

Author Affiliations: Dr DeAngelis is Editor-in-Chief and Dr Fontanarosa is Executive Deputy Editor, JAMA .

More Author Information
JAMA. 2006;295(10):1171-1172. doi:10.1001/jama.295.10.1171
Text Size: A A A
Published online

In this issue of JAMA, we are publishing the names of the 3537 peer reviewers who completed manuscript reviews for JAMA in 2005.1 We extend our sincere thanks to these dedicated reviewers, who represent virtually every discipline in biomedical science and nearly 40 countries, for their rigorous critiques and thoughtful recommendations in helping to ensure the scientific quality of articles published in JAMA.

We also appreciate the efforts of these reviewers in alerting us about ethical issues involving some submitted papers, such as several instances of duplicate submission, duplicate publication, plagiarism, and concerns about research or data integrity. Identification of these concerns is an indispensable aspect of the peer review process and is essential to maintain the scientific integrity and highest ethical standards for articles published in JAMA. We take pride in having the most stringent requirements for full disclosure of conflicts of interest, for reporting of the role of sponsors in research papers, and for insisting on oversight for aspects of studies (such as data access and statistical analysis) that might lend themselves to manipulation.2 While there is no guarantee that these measures ensure scientific honesty, we continue to seek better ways to improve this process and JAMA peer reviewers provide invaluable input in helping us to do so.

We also extend our sincere appreciation to all authors who submitted manuscripts for consideration for publication in JAMA. These authors provide JAMA readers with important, innovative, and interesting papers that span the entire spectrum of medicine, from practice-changing major clinical trials and cutting-edge scientific discoveries to practical review articles on common clinical topics and scholarly commentaries on health policy issues. The diversity of topics is shown in the “top 25” articles that were published in 2005 and were accessed most frequently from the JAMA Web site.3 In addition, authors who submit papers to JAMA reflect the international nature of medical research; in 2005, 37% of manuscripts were submitted from authors outside the United States and represented 81 different countries. We are grateful to the many physician-scientists, medical researchers, clinical investigators, and other authors of medical research reports and other manuscripts who entrust JAMA with their important work.

The rigorous nature and timeliness of the peer review process and the quality of papers submitted to JAMA are reflected in several key measures (Table). Over the past 5 years, JAMA's impact factor4 has continued to increase steadily; for 2004, the latest available value, our impact factor was 24.8. In addition, with full implementation of our Web-based system for manuscript submission and peer review in early 2005, the turnaround times for editorial decisions have continued to decrease. For instance, the mean time for reviewers to complete their reviews decreased from 26 days in 2004 to 13 days (median, 12 days) in 2005. Moreover, the overall mean publication time, ie, from manuscript submission to publication, is now 115 days (median, 110 days). With an increased number of submitted papers, the overall acceptance rate (including solicited papers, such as editorials and commentaries) has declined to approximately 8%. However, for submitted papers of good quality that cannot be published in JAMA, authors may be given the option of having their paper (along with the peer reviews) referred to one of our family of ARCHIVES specialty journals for further consideration.

Table Grahic Jump LocationTable.JAMA Peer Reviewers, Manuscript Timelines, and Impact Factor, 1999-2005

We make every effort to ensure that articles published in JAMA continue to advance medical science, enhance clinical knowledge, and reflect the highest ethical standards of medical journalism. We sincerely appreciate the contributions of all JAMA peer reviewers and all JAMA authors in helping us achieve these important goals.

Financial Disclosures: None reported.

Editorials represent the opinions of the authors and JAMA and not those of the American Medical Association.

 JAMA peer reviewers in 2005.  JAMA. 2006;2951175-1188
Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies.  JAMA. 2005;294110-111
PubMed
 Top 25 articles published in 2005 [JAMA Web site]. Available at: http://jama.ama-assn.org/misc/top25.dtl. Accessibility verified February 15, 2006
 Journal Citation Reports: 2004 JCR Science Edition. Philadelphia, Pa: Thomson Scientific; 2005. Available at: http://portal.isiknowledge.com. Accessed February 16, 2006

First Page Preview

First page PDF preview

Figures

Tables

Table Grahic Jump LocationTable.JAMA Peer Reviewers, Manuscript Timelines, and Impact Factor, 1999-2005

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

 JAMA peer reviewers in 2005.  JAMA. 2006;2951175-1188
Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies.  JAMA. 2005;294110-111
PubMed
 Top 25 articles published in 2005 [JAMA Web site]. Available at: http://jama.ama-assn.org/misc/top25.dtl. Accessibility verified February 15, 2006
 Journal Citation Reports: 2004 JCR Science Edition. Philadelphia, Pa: Thomson Scientific; 2005. Available at: http://portal.isiknowledge.com. Accessed February 16, 2006
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles